Financière de Tubize SA (TUB.BR)

EUR 116.6

(0.17%)

Total Assets Summary of Financière de Tubize SA

  • Financière de Tubize SA's latest annual total assets in 2023 was 1.92 Billion EUR , up 4.43% from previous year.
  • Financière de Tubize SA's latest quarterly total assets in 2024 Q2 was 1.92 Billion EUR , down 0.0% from previous quarter.
  • Financière de Tubize SA reported annual total assets of 1.83 Billion EUR in 2022, down -43.73% from previous year.
  • Financière de Tubize SA reported annual total assets of 3.26 Billion EUR in 2021, up 15.58% from previous year.
  • Financière de Tubize SA reported quarterly total assets of 1.92 Billion EUR for 2023 FY, up 4.43% from previous quarter.
  • Financière de Tubize SA reported quarterly total assets of 1.89 Billion EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Financière de Tubize SA (2023 - 2003)

Historical Annual Total Assets of Financière de Tubize SA (2023 - 2003)

Year Total Assets Total Assets Growth
2023 1.92 Billion EUR 4.43%
2022 1.83 Billion EUR -43.73%
2021 3.26 Billion EUR 15.58%
2020 2.82 Billion EUR 2.74%
2019 2.75 Billion EUR 10.8%
2018 2.48 Billion EUR 7.45%
2017 2.31 Billion EUR 3.98%
2016 2.22 Billion EUR -1.61%
2015 2.25 Billion EUR 23.09%
2014 1.83 Billion EUR 1.7%
2013 1.8 Billion EUR 1.05%
2012 1.78 Billion EUR -4.42%
2011 1.86 Billion EUR 4.69%
2010 1.78 Billion EUR 3.55%
2009 1.72 Billion EUR 8.73%
2008 1.58 Billion EUR -5.36%
2007 1.67 Billion EUR 4.99%
2006 1.59 Billion EUR 56.57%
2005 1.01 Billion EUR 42.46%
2004 715.25 Million EUR -9.58%
2003 791.02 Million EUR 0.0%

Peer Total Assets Comparison of Financière de Tubize SA

Name Total Assets Total Assets Difference
Nicox S.A. 52.98 Million EUR -3524.47%
European Medical Solutions 43.75 Million EUR -4288.328%
FERMENTALG 50.24 Million EUR -3721.838%
argenx SE 4.11 Billion EUR 53.303%
BioSenic S.A. 9.55 Million EUR -19988.34%
Celyad Oncology SA 16.28 Million EUR -11693.664%
Hyloris Pharmaceuticals SA 47.68 Million EUR -3927.274%
Onward Medical N.V. 43.62 Million EUR -4301.303%
Oxurion NV 6.55 Million EUR -29216.709%
PHAXIAM Therapeutics S.A. 51.3 Million EUR -3642.656%
UCB SA 15.53 Billion EUR 87.642%